Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Blood Research & Hematologic Diseases
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Gupta V Author
Subjects of specialization
Affiliation
Principle of program, Retinoid, Sufficiency Economy
Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, NJ, 07753, USA
Biography
Bajwa R, Gupta V, Khan I, Patel C, Hossain, Asif A (2019) Complement Amplifying Conditions and Atypical Hemolytic Syndrome should Eculizumab is the First Line Therapy? J Blood Res Hematol Dis 4:1.
Publications
Case Report Open Access
Complement Amplifying Conditions and Atypical Hemolytic Syndrome should Eculizumab is the First Line Therapy?
Author(s): Bajwa R,Gupta V, Khan I, Patel C, Hossain MA and Asif
Google Scholars / Researchers Sites
